Wellness Franchise Serotonin Expands in Dallas
What happened
Serotonin Anti-Aging Centers, a wellness franchise focused on longevity, awarded a five-location development agreement for the Dallas and Collin County areas in Texas. The expansion reflects growing consumer demand for physician-led, experiential wellness services.
Why it matters
- The franchise was founded in 2021 by Eric Casaburi, who previously founded and grew the Retro Fitness gym franchise to over 150 locations nationwide. - Serotonin Centers' services focus on four main areas: hormone replacement therapy, aesthetic treatments, weight control, and immunity recovery. The company has pre-negotiated partnerships for its franchisees with major brands like Allergan (Botox) and Hydrafacial. - To open a franchise, the required investment ranges from approximately $666,000 to $1.36 million, with a franchise fee of $59,000. Prospective franchisees are expected to have at least $300,000 in liquid capital. - The company has already sold the rights to nearly 100 franchise units across the U.S. as it pursues a strategy of rapid expansion. - The global anti-aging market was valued at approximately $85.13 billion in 2025 and is projected to grow to over $127 billion by 2031. - North America represented the largest share of the anti-aging market in 2025, accounting for roughly 37% of global revenue. The U.S. market alone is expected to grow at a CAGR of 6.8% between 2025 and 2030. - Key market drivers include a growing aging population and increased consumer focus on self-care and wellness, with the 40-59 age demographic holding the largest revenue share in 2024. However, younger consumers, including Millennials and Gen Z, are increasingly investing in preventative aging treatments.
Key numbers
- - The franchise was founded in 2021 by Eric Casaburi, who previously founded and grew the Retro Fitness gym franchise to over 150 locations nationwide.
- To open a franchise, the required investment ranges from approximately $666,000 to $1.36 million, with a franchise fee of $59,000.
- Prospective franchisees are expected to have at least $300,000 in liquid capital.
- The company has already sold the rights to nearly 100 franchise units across the U.S.
What happens next
- Prospective franchisees are expected to have at least $300,000 in liquid capital.
- market alone is expected to grow at a CAGR of 6.8% between 2025 and 2030.
Quick answers
What happened in Wellness Franchise Serotonin Expands in Dallas?
Serotonin Anti-Aging Centers, a wellness franchise focused on longevity, awarded a five-location development agreement for the Dallas and Collin County areas in Texas. The expansion reflects growing consumer demand for physician-led, experiential wellness services.
Why does Wellness Franchise Serotonin Expands in Dallas matter?
The franchise was founded in 2021 by Eric Casaburi, who previously founded and grew the Retro Fitness gym franchise to over 150 locations nationwide. Serotonin Centers' services focus on four main areas: hormone replacement therapy, aesthetic treatments, weight control, and immunity recovery. The company has pre-negotiated partnerships for its franchisees with major brands like Allergan (Botox) and Hydrafacial. To open a franchise, the required investment ranges from approximately $666,000 to $1.36 million, with a franchise fee of $59,000. Prospective franchisees are expected to have at least $300,000 in liquid capital. The company has already sold the rights to nearly 100 franchise units across the U.S. as it pursues a strategy of rapid expansion. The global anti-aging market was valued at approximately $85.13 billion in 2025 and is projected to grow to over $127 billion by 2031. North America represented the largest share of the anti-aging market in 2025, accounting for roughly 37% of global revenue. The U.S. market alone is expected to grow at a CAGR of 6.8% between 2025 and 2030. Key market drivers include a growing aging population and increased consumer focus on self-care and wellness, with the 40-59 age demographic holding the largest revenue share in 2024. However, younger consumers, including Millennials and Gen Z, are increasingly investing in preventative aging treatments.
